Copyright Reports & Markets. All rights reserved.

Global Pre-Menstrual Syndrome Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Analgesics (Pain Killers)
      • 1.4.3 Oral Contraceptive Pills (OCPs)
      • 1.4.4 Gonadotropin-Releasing Hormone (GnRH)
      • 1.4.5 Antidepressants
      • 1.4.6 Ovarian Suppressors
      • 1.4.7 Diuretics
      • 1.4.8 Benzodiazepines
    • 1.5 Market by Application
      • 1.5.1 Global Pre-Menstrual Syndrome Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Pre-Menstrual Syndrome Market Size
    • 2.2 Pre-Menstrual Syndrome Growth Trends by Regions
      • 2.2.1 Pre-Menstrual Syndrome Market Size by Regions (2019-2025)
      • 2.2.2 Pre-Menstrual Syndrome Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Pre-Menstrual Syndrome Market Size by by Players
      • 3.1.1 Global Pre-Menstrual Syndrome Revenue by by Players (2014-2019)
      • 3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Pre-Menstrual Syndrome Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pre-Menstrual Syndrome Key Players Head office and Area Served
    • 3.3 Key Players Pre-Menstrual Syndrome Product/Solution/Service
    • 3.4 Date of Enter into Pre-Menstrual Syndrome Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Pre-Menstrual Syndrome Market Size by Type (2014-2019)
    • 4.2 Global Pre-Menstrual Syndrome Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Pre-Menstrual Syndrome Market Size (2014-2019)
    • 5.2 Pre-Menstrual Syndrome Key Players in North America
    • 5.3 North America Pre-Menstrual Syndrome Market Size by Type
    • 5.4 North America Pre-Menstrual Syndrome Market Size by Application

    6 Europe

    • 6.1 Europe Pre-Menstrual Syndrome Market Size (2014-2019)
    • 6.2 Pre-Menstrual Syndrome Key Players in Europe
    • 6.3 Europe Pre-Menstrual Syndrome Market Size by Type
    • 6.4 Europe Pre-Menstrual Syndrome Market Size by Application

    7 China

    • 7.1 China Pre-Menstrual Syndrome Market Size (2014-2019)
    • 7.2 Pre-Menstrual Syndrome Key Players in China
    • 7.3 China Pre-Menstrual Syndrome Market Size by Type
    • 7.4 China Pre-Menstrual Syndrome Market Size by Application

    8 Japan

    • 8.1 Japan Pre-Menstrual Syndrome Market Size (2014-2019)
    • 8.2 Pre-Menstrual Syndrome Key Players in Japan
    • 8.3 Japan Pre-Menstrual Syndrome Market Size by Type
    • 8.4 Japan Pre-Menstrual Syndrome Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Pre-Menstrual Syndrome Market Size (2014-2019)
    • 9.2 Pre-Menstrual Syndrome Key Players in Southeast Asia
    • 9.3 Southeast Asia Pre-Menstrual Syndrome Market Size by Type
    • 9.4 Southeast Asia Pre-Menstrual Syndrome Market Size by Application

    10 India

    • 10.1 India Pre-Menstrual Syndrome Market Size (2014-2019)
    • 10.2 Pre-Menstrual Syndrome Key Players in India
    • 10.3 India Pre-Menstrual Syndrome Market Size by Type
    • 10.4 India Pre-Menstrual Syndrome Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Pre-Menstrual Syndrome Market Size (2014-2019)
    • 11.2 Pre-Menstrual Syndrome Key Players in Central & South America
    • 11.3 Central & South America Pre-Menstrual Syndrome Market Size by Type
    • 11.4 Central & South America Pre-Menstrual Syndrome Market Size by Application

    12 International Players Profiles

    • 12.1 Alva-Amco Pharmacal Cos., Inc.
      • 12.1.1 Alva-Amco Pharmacal Cos., Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Pre-Menstrual Syndrome Introduction
      • 12.1.4 Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2014-2019))
      • 12.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Development
    • 12.2 Bayer, Inc.
      • 12.2.1 Bayer, Inc. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Pre-Menstrual Syndrome Introduction
      • 12.2.4 Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.2.5 Bayer, Inc. Recent Development
    • 12.3 Chattem, Inc. (Sanofi)
      • 12.3.1 Chattem, Inc. (Sanofi) Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Pre-Menstrual Syndrome Introduction
      • 12.3.4 Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.3.5 Chattem, Inc. (Sanofi) Recent Development
    • 12.4 DEKK-TEC, Inc.
      • 12.4.1 DEKK-TEC, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Pre-Menstrual Syndrome Introduction
      • 12.4.4 DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.4.5 DEKK-TEC, Inc. Recent Development
    • 12.5 G. R. Lane Health Products Ltd
      • 12.5.1 G. R. Lane Health Products Ltd Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Pre-Menstrual Syndrome Introduction
      • 12.5.4 G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.5.5 G. R. Lane Health Products Ltd Recent Development
    • 12.6 McNeil Consumer Healthcare
      • 12.6.1 McNeil Consumer Healthcare Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Pre-Menstrual Syndrome Introduction
      • 12.6.4 McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.6.5 McNeil Consumer Healthcare Recent Development
    • 12.7 MetP Pharma AG
      • 12.7.1 MetP Pharma AG Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Pre-Menstrual Syndrome Introduction
      • 12.7.4 MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.7.5 MetP Pharma AG Recent Development
    • 12.8 Pherin Pharmaceuticals, Inc.
      • 12.8.1 Pherin Pharmaceuticals, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Pre-Menstrual Syndrome Introduction
      • 12.8.4 Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.8.5 Pherin Pharmaceuticals, Inc. Recent Development
    • 12.9 Umecrine Mood AB
      • 12.9.1 Umecrine Mood AB Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Pre-Menstrual Syndrome Introduction
      • 12.9.4 Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.9.5 Umecrine Mood AB Recent Development
    • 12.10 Novartis AG
      • 12.10.1 Novartis AG Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Pre-Menstrual Syndrome Introduction
      • 12.10.4 Novartis AG Revenue in Pre-Menstrual Syndrome Business (2014-2019)
      • 12.10.5 Novartis AG Recent Development
    • 12.11 GlaxoSmithKline Plc

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc.
      In 2018, the global Pre-Menstrual Syndrome market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Pre-Menstrual Syndrome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pre-Menstrual Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Alva-Amco Pharmacal Cos., Inc.
      Bayer, Inc.
      Chattem, Inc. (Sanofi)
      DEKK-TEC, Inc.
      G. R. Lane Health Products Ltd
      McNeil Consumer Healthcare
      MetP Pharma AG
      Pherin Pharmaceuticals, Inc.
      Umecrine Mood AB
      Novartis AG
      GlaxoSmithKline Plc

      Market segment by Type, the product can be split into
      Analgesics (Pain Killers)
      Oral Contraceptive Pills (OCPs)
      Gonadotropin-Releasing Hormone (GnRH)
      Antidepressants
      Ovarian Suppressors
      Diuretics
      Benzodiazepines

      Market segment by Application, split into
      Hospitals
      Clinic
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pre-Menstrual Syndrome status, future forecast, growth opportunity, key market and key players.
      To present the Pre-Menstrual Syndrome development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Pre-Menstrual Syndrome are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now